Results of GnRH Agonist Implants in Oestrous Induction and Oestrous Suppression in Bitches and Queens

Contents Over the last 10–15 years, long‐acting GnRH agonists have become widely available. In the field of small animal reproduction, most recent studies have focused on the use of two compounds developed under the form of subcutaneous implants: azagly‐nafarelin and deslorelin. Only the latter has been commercially available for use in male dogs, first in Australia and New Zealand, then in several countries of the European Union since 2008. Although officially marketed for male dogs, this compound has also been studied in bitches and more recently in queens. Some published papers or recent presentations at congresses – still unpublished – have focused on the use of GnRH agonists implants in females.